Mime Nagai

589 total citations
19 papers, 487 citations indexed

About

Mime Nagai is a scholar working on Clinical Biochemistry, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mime Nagai has authored 19 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Clinical Biochemistry, 8 papers in Pathology and Forensic Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mime Nagai's work include Advanced Glycation End Products research (15 papers), Natural Antidiabetic Agents Studies (7 papers) and Alcohol Consumption and Health Effects (5 papers). Mime Nagai is often cited by papers focused on Advanced Glycation End Products research (15 papers), Natural Antidiabetic Agents Studies (7 papers) and Alcohol Consumption and Health Effects (5 papers). Mime Nagai collaborates with scholars based in Japan, United States and India. Mime Nagai's co-authors include Ryoji Nagai, Bao Ting Zhu, Yukio Fujiwara, Allan H. Conney, Jun‐ichi Shirakawa, Hyoung‐Woo Bai, John Baynes, Hikari Sugawa, Katsumi Mera and Noriyuki Sakata and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Annals of the New York Academy of Sciences and Journal of Immunological Methods.

In The Last Decade

Mime Nagai

19 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mime Nagai Japan 14 203 142 122 117 76 19 487
Rashmi S. Tupe India 16 215 1.1× 230 1.6× 34 0.3× 147 1.3× 84 1.1× 44 625
Arvind M. Korwar India 13 185 0.9× 175 1.2× 34 0.3× 158 1.4× 57 0.8× 17 473
Chethan Sampath United States 14 57 0.3× 78 0.5× 61 0.5× 153 1.3× 67 0.9× 34 548
Kirtikar Shukla United States 16 51 0.3× 98 0.7× 53 0.4× 211 1.8× 70 0.9× 29 570
Chennam Srinivasulu Shyamaladevi India 15 69 0.3× 105 0.7× 161 1.3× 194 1.7× 82 1.1× 21 653
Ni Zheng China 10 48 0.2× 76 0.5× 59 0.5× 184 1.6× 48 0.6× 13 456
Amir M. Al Hroob Jordan 9 50 0.2× 111 0.8× 53 0.4× 150 1.3× 40 0.5× 12 479
Weronika Wojnar Poland 14 56 0.3× 96 0.7× 46 0.4× 183 1.6× 55 0.7× 21 478
Sibel Taş Türkiye 13 91 0.4× 164 1.2× 34 0.3× 118 1.0× 56 0.7× 20 563
Kuruvimalai Ekambaram Sabitha India 9 65 0.3× 87 0.6× 157 1.3× 75 0.6× 41 0.5× 9 403

Countries citing papers authored by Mime Nagai

Since Specialization
Citations

This map shows the geographic impact of Mime Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mime Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mime Nagai more than expected).

Fields of papers citing papers by Mime Nagai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mime Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mime Nagai. The network helps show where Mime Nagai may publish in the future.

Co-authorship network of co-authors of Mime Nagai

This figure shows the co-authorship network connecting the top 25 collaborators of Mime Nagai. A scholar is included among the top collaborators of Mime Nagai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mime Nagai. Mime Nagai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nagai, Mime, et al.. (2023). Mitochondrial stress and glycoxidation increase with decreased kidney function. Journal of Clinical Biochemistry and Nutrition. 72(2). 147–156. 6 indexed citations
2.
Nagai, Mime, et al.. (2022). Changes in S-(2-succinyl)cysteine and advanced glycation end-products levels in mouse tissues associated with aging. Amino Acids. 54(4). 653–661. 9 indexed citations
3.
Yamaguchi, Hiroko, Mime Nagai, Hikari Sugawa, Hisataka Yasuda, & Ryoji Nagai. (2020). Development of a conventional immunochemical detection system for determination of Nδ-(5-hydro-5-methyl-4-imidazolone-2-yl)-ornithine in methylglyoxal-modified proteins. Glycoconjugate Journal. 38(3). 293–301. 11 indexed citations
4.
Mera, Katsumi, Hiroko Ichikawa, Mime Nagai, et al.. (2019). Nω-(Carboxymethyl)arginine Is One of the Dominant Advanced Glycation End Products in Glycated Collagens and Mouse Tissues. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 28 indexed citations
5.
Sugawa, Hikari, et al.. (2017). <i>Aphanothece sacrum</i> (Sur.) Okada Prevents Cataractogenesis in Type 1 Diabetic Mice. Journal of Nutritional Science and Vitaminology. 63(4). 263–268. 14 indexed citations
6.
Shirakawa, Jun‐ichi, et al.. (2016). Soft-shelled turtle eggs inhibit the formation of AGEs in the serum and skin of diabetic rats. Journal of Clinical Biochemistry and Nutrition. 58(2). 130–134. 11 indexed citations
7.
Sugawa, Hikari, Jun‐ichi Shirakawa, Tetsuya Hirata, et al.. (2016). Eucommia ulmoides extracts prevent the formation of advanced glycation end products. Food & Function. 7(6). 2566–2573. 22 indexed citations
8.
Nagai, Ryoji, et al.. (2016). Antibody-based detection of advanced glycation end-products: promises vs. limitations. Glycoconjugate Journal. 33(4). 545–552. 17 indexed citations
9.
Shirakawa, Jun‐ichi, Hikari Sugawa, Masakazu Kobayashi, et al.. (2016). Salacia chinensis L. extract ameliorates abnormal glucose metabolism and improves the bone strength and accumulation of AGEs in type 1 diabetic rats. Food & Function. 7(6). 2508–2515. 15 indexed citations
10.
Sugawa, Hikari, Kazuhiro Maejima, Mime Nagai, et al.. (2015). Mangosteen pericarp extract inhibits the formation of pentosidine and ameliorates skin elasticity. Journal of Clinical Biochemistry and Nutrition. 57(1). 27–32. 26 indexed citations
11.
Nagai, Ryoji, et al.. (2014). Detection of AGEs as markers for carbohydrate metabolism and protein denaturation. Journal of Clinical Biochemistry and Nutrition. 55(1). 1–6. 41 indexed citations
12.
Nagai, Ryoji, et al.. (2013). Inhibition of AGEs formation by natural products. Amino Acids. 46(2). 261–266. 39 indexed citations
13.
Nagai, Ryoji, et al.. (2010). Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats. Biochemical and Biophysical Research Communications. 393(1). 118–122. 59 indexed citations
14.
Nagai, Ryoji, Katsumi Mera, Yukio Fujiwara, Mime Nagai, & Masaki Otagiri. (2008). Comparison of Pharmacokinetics between Highly and Mildly Modified AGE Proteins in Mice. Annals of the New York Academy of Sciences. 1126(1). 325–327. 3 indexed citations
15.
Nagai, Ryoji, Yukio Fujiwara, Katsumi Mera, et al.. (2008). Usefulness of Antibodies for Evaluating the Biological Significance of AGEs. Annals of the New York Academy of Sciences. 1126(1). 38–41. 18 indexed citations
16.
Mera, Katsumi, Mime Nagai, Jonathan W. C. Brock, et al.. (2008). Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products. Journal of Immunological Methods. 334(1-2). 82–90. 27 indexed citations
18.
Zhu, Bao Ting, Pan Wang, Mime Nagai, Yujing Wen, & Hyoung‐Woo Bai. (2008). Inhibition of human catechol-O-methyltransferase (COMT)-mediated O-methylation of catechol estrogens by major polyphenolic components present in coffee. The Journal of Steroid Biochemistry and Molecular Biology. 113(1-2). 65–74. 36 indexed citations
19.
Nagai, Mime, Allan H. Conney, & Bao Ting Zhu. (2004). STRONG INHIBITORY EFFECTS OF COMMON TEA CATECHINS AND BIOFLAVONOIDS ON THE O-METHYLATION OF CATECHOL ESTROGENS CATALYZED BY HUMAN LIVER CYTOSOLIC CATECHOL-O-METHYLTRANSFERASE. Drug Metabolism and Disposition. 32(5). 497–504. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026